SA
ELV icon

Seneschal Advisors’s Elevance Health ELV Stock Holding History

Seneschal Advisors’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.16K Buy
3
+2
+200% +$742 ﹤0.01% 237
2026
Q1 		$293 Sell
1
-1
-50% -$329 ﹤0.01% 480
2025
Q4 		$702 Buy
2
+1
+100% +$338 ﹤0.01% 282
2025
Q3 		$324 Buy
+1
New +$311 ﹤0.01% 459

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Seneschal Advisors's ELV Position: Q2 2026 in Review

Seneschal Advisors increased its Elevance Health (ELV) stake by 200% in Q2 2026, buying an estimated $742 and bringing the position to 3 shares worth $1.16K. The position accounts for ﹤0.01% of the portfolio, ranked #237.

Seneschal Advisors first reported a position in ELV in Q3 2025 and has held it in 4 quarters since. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Seneschal Advisors held 3 shares of Elevance Health worth $1.16K as of Q2 2026.
  • Seneschal Advisors bought 2 Elevance Health shares in Q2 2026, an estimated $742.
  • Elevance Health made up ﹤0.01% of Seneschal Advisors's portfolio in Q2 2026, its #237 holding.
  • Seneschal Advisors first reported a position in Elevance Health in Q3 2025 and has held it in 4 quarters since.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Seneschal Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.